Teva/Active Biotech Collaboration
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva and Active Biotech's proposed collaboration on the development and commercialization of laquinimod has been cleared by the Federal Trade Commission, the companies announced Aug. 24